Litcius/Paper detail

Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment start

Rodolfo Hurle, Giorgio Guazzoni, Piergiuseppe Colombo, Armando Santoro, Ottavio De Cobelli, Ettore Di Trapani, Glória Nohales, Llorente Carlos, Ramón Durán-Merino, Massimo Lazzeri

2021Urologic Oncology Seminars and Original Investigations31 citationsDOI

Topics & Concepts

MedicineTolerabilityInternal medicineDrugCystoscopyProspective cohort studyDosingGastroenterologyUrologyAdverse effectSurgeryPharmacologyUrinary systemBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrinary Tract Infections Management
Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment start | Litcius